ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Carmustine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24E9363
Home | Market Reports | Health| Pharmacy
Global Carmustine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Carmustine Market Research Report 2025

Code: QYRE-Auto-24E9363
Report
September 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amneal pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai Co Ltd
Bristol–Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals
Tianjin Kingyork

Carmustine Market

The global market for Carmustine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Carmustine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Carmustine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Carmustine include Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, Obvius Pharmaceuticals, MGI Pharma, Marcan Pharmaceuticals, Eisai, Bristol-Myers Squibb, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Carmustine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carmustine.
The Carmustine market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carmustine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carmustine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Carmustine Market Report

Report Metric Details
Report Name Carmustine Market
Segment by Type
  • 100mg Injection
  • 125mg Injection
Segment by Application
  • Glioma
  • Glioblastoma Multiforme
  • Medulloblastoma and Astrocytoma
  • Multiple Myeloma
  • Lymphoma
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, Obvius Pharmaceuticals, MGI Pharma, Marcan Pharmaceuticals, Eisai, Bristol-Myers Squibb, Pharmaplan, Sanli Ilac, Zydus Pharmaceuticals , Tianjin Kingyork
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Carmustine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Carmustine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Carmustine Market report?

Ans: The main players in the Carmustine Market are Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, Obvius Pharmaceuticals, MGI Pharma, Marcan Pharmaceuticals, Eisai, Bristol-Myers Squibb, Pharmaplan, Sanli Ilac, Zydus Pharmaceuticals, Tianjin Kingyork

What are the Application segmentation covered in the Carmustine Market report?

Ans: The Applications covered in the Carmustine Market report are Glioma, Glioblastoma Multiforme, Medulloblastoma and Astrocytoma, Multiple Myeloma, Lymphoma, Others

What are the Type segmentation covered in the Carmustine Market report?

Ans: The Types covered in the Carmustine Market report are 100mg Injection, 125mg Injection

1 Carmustine Market Overview
1.1 Product Definition
1.2 Carmustine by Type
1.2.1 Global Carmustine Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg Injection
1.2.3 125mg Injection
1.3 Carmustine by Application
1.3.1 Global Carmustine Market Value by Application (2024 VS 2031)
1.3.2 Glioma
1.3.3 Glioblastoma Multiforme
1.3.4 Medulloblastoma and Astrocytoma
1.3.5 Multiple Myeloma
1.3.6 Lymphoma
1.3.7 Others
1.4 Global Carmustine Market Size Estimates and Forecasts
1.4.1 Global Carmustine Revenue 2020-2031
1.4.2 Global Carmustine Sales 2020-2031
1.4.3 Global Carmustine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Carmustine Market Competition by Manufacturers
2.1 Global Carmustine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Carmustine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Carmustine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Carmustine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carmustine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carmustine, Product Type & Application
2.7 Global Key Manufacturers of Carmustine, Date of Enter into This Industry
2.8 Global Carmustine Market Competitive Situation and Trends
2.8.1 Global Carmustine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Carmustine Players Market Share by Revenue
2.8.3 Global Carmustine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Carmustine Market Scenario by Region
3.1 Global Carmustine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Carmustine Sales by Region: 2020-2031
3.2.1 Global Carmustine Sales by Region: 2020-2025
3.2.2 Global Carmustine Sales by Region: 2026-2031
3.3 Global Carmustine Revenue by Region: 2020-2031
3.3.1 Global Carmustine Revenue by Region: 2020-2025
3.3.2 Global Carmustine Revenue by Region: 2026-2031
3.4 North America Carmustine Market Facts & Figures by Country
3.4.1 North America Carmustine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Carmustine Sales by Country (2020-2031)
3.4.3 North America Carmustine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carmustine Market Facts & Figures by Country
3.5.1 Europe Carmustine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Carmustine Sales by Country (2020-2031)
3.5.3 Europe Carmustine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carmustine Market Facts & Figures by Region
3.6.1 Asia Pacific Carmustine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Carmustine Sales by Region (2020-2031)
3.6.3 Asia Pacific Carmustine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carmustine Market Facts & Figures by Country
3.7.1 Latin America Carmustine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Carmustine Sales by Country (2020-2031)
3.7.3 Latin America Carmustine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carmustine Market Facts & Figures by Country
3.8.1 Middle East and Africa Carmustine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Carmustine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Carmustine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carmustine Sales by Type (2020-2031)
4.1.1 Global Carmustine Sales by Type (2020-2025)
4.1.2 Global Carmustine Sales by Type (2026-2031)
4.1.3 Global Carmustine Sales Market Share by Type (2020-2031)
4.2 Global Carmustine Revenue by Type (2020-2031)
4.2.1 Global Carmustine Revenue by Type (2020-2025)
4.2.2 Global Carmustine Revenue by Type (2026-2031)
4.2.3 Global Carmustine Revenue Market Share by Type (2020-2031)
4.3 Global Carmustine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Carmustine Sales by Application (2020-2031)
5.1.1 Global Carmustine Sales by Application (2020-2025)
5.1.2 Global Carmustine Sales by Application (2026-2031)
5.1.3 Global Carmustine Sales Market Share by Application (2020-2031)
5.2 Global Carmustine Revenue by Application (2020-2031)
5.2.1 Global Carmustine Revenue by Application (2020-2025)
5.2.2 Global Carmustine Revenue by Application (2026-2031)
5.2.3 Global Carmustine Revenue Market Share by Application (2020-2031)
5.3 Global Carmustine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amneal Pharms
6.1.1 Amneal Pharms Company Information
6.1.2 Amneal Pharms Description and Business Overview
6.1.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amneal Pharms Carmustine Product Portfolio
6.1.5 Amneal Pharms Recent Developments/Updates
6.2 Arbor Pharms
6.2.1 Arbor Pharms Company Information
6.2.2 Arbor Pharms Description and Business Overview
6.2.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arbor Pharms Carmustine Product Portfolio
6.2.5 Arbor Pharms Recent Developments/Updates
6.3 Emcure Pharms
6.3.1 Emcure Pharms Company Information
6.3.2 Emcure Pharms Description and Business Overview
6.3.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Emcure Pharms Carmustine Product Portfolio
6.3.5 Emcure Pharms Recent Developments/Updates
6.4 Navinta
6.4.1 Navinta Company Information
6.4.2 Navinta Description and Business Overview
6.4.3 Navinta Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Navinta Carmustine Product Portfolio
6.4.5 Navinta Recent Developments/Updates
6.5 STI Pharma
6.5.1 STI Pharma Company Information
6.5.2 STI Pharma Description and Business Overview
6.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 STI Pharma Carmustine Product Portfolio
6.5.5 STI Pharma Recent Developments/Updates
6.6 Obvius Pharmaceuticals
6.6.1 Obvius Pharmaceuticals Company Information
6.6.2 Obvius Pharmaceuticals Description and Business Overview
6.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Obvius Pharmaceuticals Carmustine Product Portfolio
6.6.5 Obvius Pharmaceuticals Recent Developments/Updates
6.7 MGI Pharma
6.7.1 MGI Pharma Company Information
6.7.2 MGI Pharma Description and Business Overview
6.7.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MGI Pharma Carmustine Product Portfolio
6.7.5 MGI Pharma Recent Developments/Updates
6.8 Marcan Pharmaceuticals
6.8.1 Marcan Pharmaceuticals Company Information
6.8.2 Marcan Pharmaceuticals Description and Business Overview
6.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Marcan Pharmaceuticals Carmustine Product Portfolio
6.8.5 Marcan Pharmaceuticals Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Company Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Eisai Carmustine Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bristol-Myers Squibb Carmustine Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Pharmaplan
6.11.1 Pharmaplan Company Information
6.11.2 Pharmaplan Description and Business Overview
6.11.3 Pharmaplan Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pharmaplan Carmustine Product Portfolio
6.11.5 Pharmaplan Recent Developments/Updates
6.12 Sanli Ilac
6.12.1 Sanli Ilac Company Information
6.12.2 Sanli Ilac Description and Business Overview
6.12.3 Sanli Ilac Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanli Ilac Carmustine Product Portfolio
6.12.5 Sanli Ilac Recent Developments/Updates
6.13 Zydus Pharmaceuticals
6.13.1 Zydus Pharmaceuticals  Company Information
6.13.2 Zydus Pharmaceuticals  Description and Business Overview
6.13.3 Zydus Pharmaceuticals  Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zydus Pharmaceuticals  Carmustine Product Portfolio
6.13.5 Zydus Pharmaceuticals  Recent Developments/Updates
6.14 Tianjin Kingyork
6.14.1 Tianjin Kingyork Company Information
6.14.2 Tianjin Kingyork Description and Business Overview
6.14.3 Tianjin Kingyork Carmustine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Tianjin Kingyork Carmustine Product Portfolio
6.14.5 Tianjin Kingyork Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carmustine Industry Chain Analysis
7.2 Carmustine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carmustine Production Mode & Process Analysis
7.4 Carmustine Sales and Marketing
7.4.1 Carmustine Sales Channels
7.4.2 Carmustine Distributors
7.5 Carmustine Customer Analysis
8 Carmustine Market Dynamics
8.1 Carmustine Industry Trends
8.2 Carmustine Market Drivers
8.3 Carmustine Market Challenges
8.4 Carmustine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amneal pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai Co Ltd
Bristol–Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals
Tianjin Kingyork
List of Tables
 Table 1. Global Carmustine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Carmustine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Carmustine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Carmustine Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Carmustine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Carmustine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Carmustine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Carmustine Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Carmustine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Carmustine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Carmustine, Product Type & Application
 Table 12. Global Key Manufacturers of Carmustine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Carmustine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carmustine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Carmustine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Carmustine Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Carmustine Sales Market Share by Region (2020-2025)
 Table 19. Global Carmustine Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Carmustine Sales Market Share by Region (2026-2031)
 Table 21. Global Carmustine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Carmustine Revenue Market Share by Region (2020-2025)
 Table 23. Global Carmustine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Carmustine Revenue Market Share by Region (2026-2031)
 Table 25. North America Carmustine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Carmustine Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Carmustine Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Carmustine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Carmustine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Carmustine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Carmustine Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Carmustine Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Carmustine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Carmustine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Carmustine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Carmustine Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Carmustine Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Carmustine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Carmustine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Carmustine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Carmustine Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Carmustine Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Carmustine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Carmustine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Carmustine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Carmustine Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Carmustine Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Carmustine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Carmustine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Carmustine Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Carmustine Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Carmustine Sales Market Share by Type (2020-2025)
 Table 53. Global Carmustine Sales Market Share by Type (2026-2031)
 Table 54. Global Carmustine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Carmustine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Carmustine Revenue Market Share by Type (2020-2025)
 Table 57. Global Carmustine Revenue Market Share by Type (2026-2031)
 Table 58. Global Carmustine Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Carmustine Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Carmustine Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Carmustine Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Carmustine Sales Market Share by Application (2020-2025)
 Table 63. Global Carmustine Sales Market Share by Application (2026-2031)
 Table 64. Global Carmustine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Carmustine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Carmustine Revenue Market Share by Application (2020-2025)
 Table 67. Global Carmustine Revenue Market Share by Application (2026-2031)
 Table 68. Global Carmustine Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Carmustine Price (USD/Pcs) by Application (2026-2031)
 Table 70. Amneal Pharms Company Information
 Table 71. Amneal Pharms Description and Business Overview
 Table 72. Amneal Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Amneal Pharms Carmustine Product
 Table 74. Amneal Pharms Recent Developments/Updates
 Table 75. Arbor Pharms Company Information
 Table 76. Arbor Pharms Description and Business Overview
 Table 77. Arbor Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Arbor Pharms Carmustine Product
 Table 79. Arbor Pharms Recent Developments/Updates
 Table 80. Emcure Pharms Company Information
 Table 81. Emcure Pharms Description and Business Overview
 Table 82. Emcure Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Emcure Pharms Carmustine Product
 Table 84. Emcure Pharms Recent Developments/Updates
 Table 85. Navinta Company Information
 Table 86. Navinta Description and Business Overview
 Table 87. Navinta Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Navinta Carmustine Product
 Table 89. Navinta Recent Developments/Updates
 Table 90. STI Pharma Company Information
 Table 91. STI Pharma Description and Business Overview
 Table 92. STI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. STI Pharma Carmustine Product
 Table 94. STI Pharma Recent Developments/Updates
 Table 95. Obvius Pharmaceuticals Company Information
 Table 96. Obvius Pharmaceuticals Description and Business Overview
 Table 97. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Obvius Pharmaceuticals Carmustine Product
 Table 99. Obvius Pharmaceuticals Recent Developments/Updates
 Table 100. MGI Pharma Company Information
 Table 101. MGI Pharma Description and Business Overview
 Table 102. MGI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. MGI Pharma Carmustine Product
 Table 104. MGI Pharma Recent Developments/Updates
 Table 105. Marcan Pharmaceuticals Company Information
 Table 106. Marcan Pharmaceuticals Description and Business Overview
 Table 107. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Marcan Pharmaceuticals Carmustine Product
 Table 109. Marcan Pharmaceuticals Recent Developments/Updates
 Table 110. Eisai Company Information
 Table 111. Eisai Description and Business Overview
 Table 112. Eisai Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Eisai Carmustine Product
 Table 114. Eisai Recent Developments/Updates
 Table 115. Bristol-Myers Squibb Company Information
 Table 116. Bristol-Myers Squibb Description and Business Overview
 Table 117. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Bristol-Myers Squibb Carmustine Product
 Table 119. Bristol-Myers Squibb Recent Developments/Updates
 Table 120. Pharmaplan Company Information
 Table 121. Pharmaplan Description and Business Overview
 Table 122. Pharmaplan Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Pharmaplan Carmustine Product
 Table 124. Pharmaplan Recent Developments/Updates
 Table 125. Sanli Ilac Company Information
 Table 126. Sanli Ilac Description and Business Overview
 Table 127. Sanli Ilac Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Sanli Ilac Carmustine Product
 Table 129. Sanli Ilac Recent Developments/Updates
 Table 130. Zydus Pharmaceuticals  Company Information
 Table 131. Zydus Pharmaceuticals  Description and Business Overview
 Table 132. Zydus Pharmaceuticals  Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Zydus Pharmaceuticals  Carmustine Product
 Table 134. Zydus Pharmaceuticals  Recent Developments/Updates
 Table 135. Tianjin Kingyork Company Information
 Table 136. Tianjin Kingyork Description and Business Overview
 Table 137. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Tianjin Kingyork Carmustine Product
 Table 139. Tianjin Kingyork Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Carmustine Distributors List
 Table 143. Carmustine Customers List
 Table 144. Carmustine Market Trends
 Table 145. Carmustine Market Drivers
 Table 146. Carmustine Market Challenges
 Table 147. Carmustine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Carmustine
 Figure 2. Global Carmustine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Carmustine Market Share by Type: 2024 & 2031
 Figure 4. 100mg Injection Product Picture
 Figure 5. 125mg Injection Product Picture
 Figure 6. Global Carmustine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Carmustine Market Share by Application: 2024 & 2031
 Figure 8. Glioma
 Figure 9. Glioblastoma Multiforme
 Figure 10. Medulloblastoma and Astrocytoma
 Figure 11. Multiple Myeloma
 Figure 12. Lymphoma
 Figure 13. Others
 Figure 14. Global Carmustine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Carmustine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Carmustine Sales (2020-2031) & (K Pcs)
 Figure 17. Global Carmustine Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Carmustine Report Years Considered
 Figure 19. Carmustine Sales Share by Manufacturers in 2024
 Figure 20. Global Carmustine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Carmustine Players: Market Share by Revenue in Carmustine in 2024
 Figure 22. Carmustine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Carmustine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Carmustine Sales Market Share by Country (2020-2031)
 Figure 25. North America Carmustine Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Carmustine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Carmustine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Carmustine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Carmustine Revenue Market Share by Region (2020-2031)
 Figure 37. China Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Carmustine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Carmustine Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Carmustine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Carmustine Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Carmustine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Carmustine by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Carmustine by Type (2020-2031)
 Figure 59. Global Carmustine Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Carmustine by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Carmustine by Application (2020-2031)
 Figure 62. Global Carmustine Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Carmustine Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Carmustine Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Carbamate Market Research Report 2025
Global Carnitine Series Products Market Research Report 2025
Global Medium Cars Market Research Report 2025
Global CAR T Drugs Market Research Report 2024
Global Carbazide Market Research Report 2025
Global Carbetocin Market Research Report 2025
Global Car 3 ene Market Research Report 2025
Global Target Car Market Research Report 2024
Global Medium Sized Cars Market Research Report 2025
Car2Car Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Memantine Market Research Report 2025
Global Railroad Car Market Research Report 2024
Global Car Ferry Market Research Report 2024
Global Mid Size Cars Market Research Report 2025
Global Carmoisine Powder Market Research Report 2025
Global Rolling Car Market Research Report 2024
Global Semustine Capsules Market Research Report 2024
Global Car Tracker Market Research Report 2024
Global Car Tuning Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions